Literature DB >> 12819087

HEp-2 cell adherence, actin aggregation, and intimin types of attaching and effacing Escherichia coli strains isolated from healthy infants in Germany and Australia.

Lothar Beutin1, Olivier Marchés, Karl A Bettelheim, Kerstin Gleier, Sonja Zimmermann, Herbert Schmidt, Eric Oswald.   

Abstract

Fecal samples from healthy children under 2 years of age living in Berlin, Germany (205 infants), and Melbourne, Australia (184 infants), were investigated for the presence of attaching and effacing (AE) Escherichia coli (AEEC) strains by screening for eae (intimin) genes. Twenty-seven AEEC strains were isolated from 14 children (7.6%) from Melbourne and from 12 children (5.9%) from Berlin. The 27 AEEC strains were classified as enterohemorrhagic E. coli (one strain, producing Shiga toxin 1), typical enteropathogenic E. coli (EPEC) (one strain carrying an EPEC adherence factor [EAF] plasmid), and atypical EPEC (25 strains negative for Shiga toxins and EAF plasmids). The AEEC were divided into 18 different serotypes, O-nontypeable and O-rough strains. Typing of their intimin genes revealed the presence of intimin alpha in 6 strains, intimin beta in 11 strains, intimin gamma in 7 strains, intimin zeta in 2 strains, and intimin eta in one strain. Analysis of HEp-2 cell adherence showed diffuse adherence or localized adherence-like patterns in 26 AEEC strains; local adherence was found only with the EAF-positive strain. Ten AEEC strains showed an AE property with the fluorescent actin staining (FAS) test. The introduction of an EAF plasmid (pMAR7) converted 11 FAS-negative AEEC strains to FAS positive and increased the FAS reaction in six FAS-positive AEEC strains, indicating that the genes needed for the AE phenotype were functional in these strains. Our finding indicates that atypical EPEC strains could play a double role as strains that naturally immunize against intimin in humans and as reservoirs for new emerging human pathogenic EPEC strains.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12819087      PMCID: PMC162008          DOI: 10.1128/IAI.71.7.3995-4002.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  63 in total

1.  Identification of a novel genetic locus that is required for in vitro adhesion of a clinical isolate of enterohaemorrhagic Escherichia coli to epithelial cells.

Authors:  L Nicholls; T H Grant; R M Robins-Browne
Journal:  Mol Microbiol       Date:  2000-01       Impact factor: 3.501

2.  Investigation of human infections with verocytotoxin-producing strains of Escherichia coli (VTEC) belonging to serogroup O118 with evidence for zoonotic transmission.

Authors:  L Beutin; M Bülte; A Weber; S Zimmermann; K Gleier
Journal:  Epidemiol Infect       Date:  2000-08       Impact factor: 2.451

Review 3.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

Review 4.  Exploitation of host cells by enteropathogenic Escherichia coli.

Authors:  B A Vallance; B B Finlay
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

5.  Phenotypic and genotypic characteristics of Escherichia coli strains of non-enteropathogenic E. coli (EPEC) serogroups that carry EAE and lack the EPEC adherence factor and Shiga toxin DNA probe sequences.

Authors:  M A Vieira; J R Andrade; L R Trabulsi; A C Rosa; A M Dias; S R Ramos; G Frankel; T A Gomes
Journal:  J Infect Dis       Date:  2001-02-08       Impact factor: 5.226

6.  Genetic diversity of intimin genes of attaching and effacing Escherichia coli strains.

Authors:  W L Zhang; B Köhler; E Oswald; L Beutin; H Karch; S Morabito; A Caprioli; S Suerbaum; H Schmidt
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

7.  Role of tir and intimin in the virulence of rabbit enteropathogenic Escherichia coli serotype O103:H2.

Authors:  O Marchès; J P Nougayrède; S Boullier; J Mainil; G Charlier; I Raymond; P Pohl; M Boury; J De Rycke; A Milon; E Oswald
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

8.  Typing of intimin genes in human and animal enterohemorrhagic and enteropathogenic Escherichia coli: characterization of a new intimin variant.

Authors:  E Oswald; H Schmidt; S Morabito; H Karch; O Marchès; A Caprioli
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

9.  Identification of Escherichia coli flagellar types by restriction of the amplified fliC gene.

Authors:  J Machado; F Grimont; P A Grimont
Journal:  Res Microbiol       Date:  2000-09       Impact factor: 3.992

10.  Serotypes of Escherichia coli isolated from healthy infants in Berlin, Germany and Melbourne, Australia.

Authors:  K A Bettelheim; L Beutin; K Gleier; J L Pearce; R K J Luke; S Zimmermann
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2003-01       Impact factor: 2.268

View more
  21 in total

1.  Phylogenetic background of attaching and effacing Escherichia coli isolates from animals.

Authors:  C Tramuta; P Robino; P Nebbia
Journal:  Vet Res Commun       Date:  2008-05-29       Impact factor: 2.459

2.  Bovine feces from animals with gastrointestinal infections are a source of serologically diverse atypical enteropathogenic Escherichia coli and Shiga toxin-producing E. coli strains that commonly possess intimin.

Authors:  Michael A Hornitzky; Kim Mercieca; Karl A Bettelheim; Steven P Djordjevic
Journal:  Appl Environ Microbiol       Date:  2005-07       Impact factor: 4.792

3.  Identification of virulence genes linked with diarrhea due to atypical enteropathogenic Escherichia coli by DNA microarray analysis and PCR.

Authors:  Jan Egil Afset; Guillaume Bruant; Roland Brousseau; Josée Harel; Endre Anderssen; Lars Bevanger; Kåre Bergh
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

4.  Comparison of virulence gene profiles of Escherichia coli strains isolated from healthy and diarrheic swine.

Authors:  Toni A Chapman; Xi-Yang Wu; Idris Barchia; Karl A Bettelheim; Steven Driesen; Darren Trott; Mark Wilson; James J-C Chin
Journal:  Appl Environ Microbiol       Date:  2006-07       Impact factor: 4.792

5.  Association of Atypical Enteropathogenic Escherichia coli with Diarrhea and Related Mortality in Kittens.

Authors:  Victoria E Watson; Megan E Jacob; James R Flowers; Sandra J Strong; Chitrita DebRoy; Jody L Gookin
Journal:  J Clin Microbiol       Date:  2017-06-28       Impact factor: 5.948

6.  Specific properties of enteropathogenic Escherichia coli isolates from diarrheal patients and comparison to strains from foods and fecal specimens from cattle, swine, and healthy carriers in Osaka City, Japan.

Authors:  Lili Wang; Mitsuko Wakushima; Tetsu Aota; Yuka Yoshida; Toshimasa Kita; Tomofumi Maehara; Jun Ogasawara; Changsun Choi; Yoichi Kamata; Yukiko Hara-Kudo; Yoshikazu Nishikawa
Journal:  Appl Environ Microbiol       Date:  2012-12-07       Impact factor: 4.792

7.  Characterization of Shiga toxin-producing Escherichia coli strains isolated from human patients in Germany over a 3-year period.

Authors:  Lothar Beutin; Gladys Krause; Sonja Zimmermann; Stefan Kaulfuss; Kerstin Gleier
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

8.  Comparative analysis of the locus of enterocyte effacement and its flanking regions.

Authors:  Daniel Müller; Inga Benz; Ariane Liebchen; Inka Gallitz; Helge Karch; M Alexander Schmidt
Journal:  Infect Immun       Date:  2009-06-08       Impact factor: 3.441

9.  Clonal relationship among atypical enteropathogenic Escherichia coli strains isolated from different animal species and humans.

Authors:  Rodrigo A Moura; Marcelo P Sircili; Luciana Leomil; Maria Helena Matté; Luiz R Trabulsi; Waldir P Elias; Kinue Irino; Antonio F Pestana de Castro
Journal:  Appl Environ Microbiol       Date:  2009-10-02       Impact factor: 4.792

10.  Attaching and effacing Escherichia coli downregulate DNA mismatch repair protein in vitro and are associated with colorectal adenocarcinomas in humans.

Authors:  Oliver D K Maddocks; Abigail J Short; Michael S Donnenberg; Scott Bader; David J Harrison
Journal:  PLoS One       Date:  2009-05-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.